This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product Segments - Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines).
The report provides separate comprehensive analytics for the US, Europe, and Rest of World.
Annual estimates and forecasts are provided for each region for the period 2009 through 2017.
A six-year historic analysis is also provided for these markets.
The report profiles 69 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Merck Animal Health, Merial Ltd., Pfizer, Inc., Pfizer Animal Health Global Poultry, Fort Dodge Animal Health, Protein Sciences Corporation, and Virbac Corporation.
Market data and analytics are derived from primary and secondary research.
Company profiles are primarily based upon search engine sources in the public domain.
The report provides separate comprehensive analytics for the US, Europe, and Rest of World.
Annual estimates and forecasts are provided for each region for the period 2009 through 2017.
A six-year historic analysis is also provided for these markets.
The report profiles 69 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Merck Animal Health, Merial Ltd., Pfizer, Inc., Pfizer Animal Health Global Poultry, Fort Dodge Animal Health, Protein Sciences Corporation, and Virbac Corporation.
Market data and analytics are derived from primary and secondary research.
Company profiles are primarily based upon search engine sources in the public domain.
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. Companion Animal Vaccines
B. Livestock Vaccines
Porcine Vaccines
Bovine Vaccines
Poultry Vaccines
Ovine Vaccines
Equine Vaccines
Other Animal Vaccines
II. EXECUTIVE SUMMARY1.INDUSTRY OVERVIEW & OUTLOOK
Global Animal Health Care Industry - A Brief Review
Animal Healthcare Market Grows Amidst Recession
Veterinary Vaccines Industry Posts Moderate Growth
Poultry Vaccines Industry: A Global Scenario
Improved Manufacturing Techniques
Improved Analysis
Scope of the Report
2.MARKET TRENDS & ISSUES
Companion Animal Vaccines: Trailing on a High Growth Track
OTC Market: A Potential Threat for Veterinarians
Small Animal Practitioners Feel the Pinch of Recession
Parasiticides, Systemic Agents To Drive The Market
Taxonomy of Vaccines
Bird Flu – The Aftermath
Vaccination – Critical for Controlling Avian Influenza Virus
3.PRODUCT OVERVIEW
Vaccines - An Evolutionary Scan
Contribution of Animal Research to Vaccine Production
Veterinary Medicines- A Brief Review
Preventive Medicines
Therapeutic Medicines
Others
Development of Vaccines
Production of Vaccines
Veterinary Vaccines – An Essential Component of Animal Health Care
What Does A Veterinary Vaccine Do?
Classification of Veterinary Vaccines
Companion Animals Vaccines
Canine Vaccines
Feline Vaccines
Livestock Vaccines
Bovine Vaccines
Poultry Vaccines
Ovine Vaccines
Porcine Vaccines
Equine Vaccines
Aquaculture Vaccines
A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
Vaccination and Its Reactions
Veterinary Vaccines- Latest Breakthroughs
Marker vaccines
DNA vaccines
Gene-deleted vaccines
Viral-vectored vaccines
4.NOTES ON SELECT ANIMAL DISEASES
Brucellosis
Tuberculosis
Johne’s disease
Spirochete Associated Diseases
Respiratory Disease in Goats, Sheep, and Cattle
Porcine Respiratory Diseases
Mastitis
African Swine Fever
Avian Influenza
East Coast Fever
Hemorrhagic Septicemia
Foot-And-Mouth Disease
Japanese Encephalitis
Rift Valley Fever
Equine Virus
5.PRODUCT INNOVATIONS/INTRODUCTIONS
Intervet/Schering-Plough Animal Health Introduces a New Web Site for Innovax recombinant Vaccines Product Line
Pfizer Animal Health Introduces the First E. Coli Bacterial Extract Vaccine
Intervet Schering-Plough Animal Health Re-Launches EQUILIS® StrepE for Horses
Boehringer Ingelheim Vetmedica Launches Single Shot 3FLEX combination package PL
Pfizer Animal Health Launches INFORCE™ 3
Boehringer Ingelheim Introduces Ingelvac CircoFLEX® in Russia
Pfizer Animal Health Introduces Bopriva® for Bull and Beef Market in NZ
GALVmed, Inter-African Bureau for Animal Resources Launch ECF Vaccine
BIVI launches Five New Variants of Vetera® Vaccines
Hipra Announces Launch of Suiseng®
Aceto Corporation Receives Approval to Sell Suppliera[euro]™ in the US
Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs
Intervet Schering-Plough Animal Health Introduces PORCILIS PCV Vaccine
Lohmann Launches AviPro® MEGAN®VAC Vaccination for Salmonella Disease
Intervet Schering Plough Animal Health Introduces Circovirosis Vaccine
Pfizer Animal Health Develops Inovocox® Vaccine
Intervet/Schering-Plough Animal Health Launches Bravoxin 10
Bioject and Merial Rolls Out Derma-Vac NF
Defra to Launch Bovine Tuberculosis Vaccine
6.PRODUCT INTRODUCTIONS/INNOVATIONS – A HISTORIC PERSPECTIVE BUILDER
Intervet International Develops Bluetongue Vaccine
Hester Biosciences Unveils Anti-Coryza Vaccine
Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8 Vaccine
Tecnovax Develops Vaccine for Salmon Virus
Tamil Nadu Veterinary and Animal Science University and The Indian Veterinary Research Institute Develop Vaccine
Lohmann Animal Health Develops AviPro IBD Xtreme
Intervet/Schering-Plough Animal Health Launches EquiRab™
Lohmann Animal Health Introduces Larger Doses of AviPro® ViBursa CE
Lohmann Animal Health International Rolls Out AviBlue
Fort Dodge Animal Health Unveils West Nile-Innovator DNA
Univet Agricultural Products Introduces Coglapest
Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C
Pfizer Animal Health Unveils FluSure® XP Defense System
Pfizer Animal Health Launches Improvac®
Intervet/Schering-Plough Animal Health Develops Onset™ 5 Intranasal (IN) Vaccine
Merial Rolls Out BTVPUR AlSap 8
Pfizer Animal Health Introduces FarrowSure® GOLD and FarrowSure® GOLD B
Schering-Plough Animal Health Unveils CAVALRY 9
Lohmann Animal Health Develops BTO2 REO Vaccine
Agroinsuvet Introduces New Vaccines
Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for Poultry Industry
Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine Prototype for Birds
Schering-Plough Receives USDA License for its Rhusigen™ Erysipelas Vaccine
USDA Approves Use of PreveNile™ Vaccine for Horses
Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine
Boehringer Ingelheim’s Swine Vaccine Gains Approval in Australia
Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs
Embrex’s Poultry Vaccine Inovocox Gets USDA Approval
Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine
United States Department of Agriculture Grants Conditional License for Necrotic Enteritis Vaccine
Fort Dodge Receives USDA License for Pyramid®10
USDA Licenses Use of Fort Dodge’s Suvaxyn® PCV2 Vaccine in Pigs
USDA Grants Conditional License to Pfizer’s New Canine Vaccine
7.RECENT INDUSTRY ACTIVITY
Pfizer to Restructure Indian Animal Health Unit
Pfizer Poultry Health Acquires Alpharma
Intervet/Schering-Plough Animal Health Becomes Merck Animal Health
Centegen Enters into Licensing Partnership with Merial
The Ugandan Government Enters into Partnership with Brentec Vaccines International
Pfizer Animal Health Kicks Off Equine Business Unit
Pfizer Animal Health Acquires Microtek
GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine
Pfizer Animal Health Inks Global Licensing Deal with Epitopix
Indian Immunologicals Intends to Establish a New Facility in Hyderabad
Pfizer Phases out Animal Vaccine Manufacturing Unit of Wyeth in the Netherlands
Vivalis Signs Commercial License for EB66® Cell Line Platform
Ibio Grants Rights of iBioLaunch platform to Government Funded Project
Intervet/Schering-Plough Animal Health Unveils Production Center at Boxmeer
Globion India Announced Plans to Develop Eight New Vaccines
Veterinary Services Department Intends to Upgrade VRI
VIVALIS Grants Rights of EB66® Cell Line To KYOTO BIKEN
Vical Enters Into Agreement with GenomIdea for Development of DNA Vaccine
Intervet/Schering-Plough Animal Health Unveils the New Freeze-drying and Specialized Central Filling Unit
Him Electronics Enters into Partnership with Hester Bioscience to Produce Animal Vaccines
Intervet/Schering-Plough Animal Health Receives Approval for Nobivac Lepto4
Biolex Enters into Collaboration With Merial for Research and Development
Intervet/Schering-Plough Animal Health Receives Full License from USDA for Nobivac® Vaccine
Intercell Inks License Agreement with Boehringer
Intervet/Schering-Plough Recalls PreveNile West Nile Virus Vaccine in the US
Merial Gains Full License of ONCEPT™ from USDA
Virbac Acquires Veterinary Assets from Pfizer
Harbin Pharmaceutical Group Holding Acquires Animal Vaccine Business From Pfizer
Boehringer Ingelheim Acquires Certain Cattle Vaccines from Fort Dodge
Virbac Acquires 30% Share in Santa Elena
Merck and Sanofi-Aventis to Merge their Animal Health Business
Elanco to Take Over Pfizer’s Animal Health Products Portfolio
Boehringer Ingelhei to Acquire Pfizer’s Fort Dodge Animal Health Unit
ImmunoVaccine Inks Deal with Pfizer
Merck Merges with Schering-Plough
Pfizer Acquires Wyeth
Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine
Epitopix Obtains Approval to Sell Siderophore Receptor and Porin Vaccine
Phibro Animal Health Acquires Animal Health Division of Abic
Fort Dodge Animal Health and Vivalis Sign Commercial License Deal
Hester Biosciences Expands Gujarat Based Facility
Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR Vaccine with Bovilis® IBR Marker Live
Tangshan Yian Biological Engineering Wins Approval from Ministry of Agriculture of China
Lohmann Animal Health International Signs an Agreement with Celldex Therapeutics
Intervet/Schering-Plough Animal Health Starts New Manufacturing Facility
Laprovet Commences New Facility
ImmunoVaccine Technologies and La Jolla Institute for Allergy & Immunology Enter into an Agreement
Merial Signs a Toll Distribution and Manufacturing Agreement with Newport Laboratories
BOEHRINGER INGELHEIM Animal Health Signs Research License Deal with Vivalis
AviTech Selects Merial as a Distributor and Service Provider
8.STRATEGIC CORPORATE DEVELOPMENTS – A HISTORIC PERSPECTIVE BUILDER
Bayer Inks Agreement with Juvaris
Pfizer Inks Agreement with ImmunoVaccine Technologies
BioVet Inaugurates BSL-4 Production Unit in India
Vaxine to Take over Protein Sciences
Pfizer Inaugurates a New Development Facility for Veterinary Vaccines
Merial to Establish Animal Vaccine Manufacturing Plant
BNC Bioniche Life Sciences Bags Approval to Sell Econiche Vaccines
Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division
Pfizer's Animal Health Unit Acquires Schering-Plough's Product License in Europe
Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario
Harbin Veterinary Research Institute Opens Animal Vaccine Manufacturing Base
Bioject Medical Technologies Enters into a Long-Term Supply, Development and License Contract with Merial
Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough
Biochemiq Enters into Partnership with Labovet
Microbix Biosystems Purchases Production Plant
Beijing Veterinary Biological Product Factory Starts Operation in New Plant
Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine Facility
Schering-Plough to Sell Health Products of Animals to Pfizer and Virbac
Pfizer Group Establishes a Veterinary Vaccines Development Center
Phylaxia to Acquire Gazdasagi Radio and Kozep-europai Gazterminal Zrt
Bayer HealthCare AG's Animal Health Unit Enters into Licensing Agreement with Juvaris BioTherapeutics
Vivalis Enters into a Commercial License Contract with Virbac
ImmunoVaccine Technologies Signs Licensing Agreement with Pfizer Animal Health
Kaketsuken and Vivalis Extends Research Collaboration
Heska Amends Distribution Contract with Agri Laboratories
Prevtec Microbia and Saskatchewan Research Council Receives Approval to Market and Manufacture Coliprotec
Imugene and Merial Enter into an Agreement
Celldex Therapeutics Merges with AVANT Immunotherapeutics’ Subsidiary
Ceva Sante Animale Acquires Delvet
Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals
Environmental Risk Management Authority Approves equine Influenza Vaccine
Functional Technologies Commences Operations of Phyterra Bio
Summit VetPharm Enters into Distribution Partnership with Webster Veterinary Unit
PerOs Receives Establishment and Bacterin License from USDA
Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines
Boehringer Ingelheim Vetmedica Receives Approval for Express® FP and Express® Vaccines from the USDA
Merial Bags Major Australian Contract
United States Department of Agriculture Approves Intervet Vaccine
Merial Pockets Ancare
Heska Revises Distribution Agreement with AgriLabs
Animal Health International Acquires Kane Veterinary Supplies
Industrial Equity Investments Pockets Arysta LifeScience
Henry Schein Acquires W&J Dunlop
Tecnovax Establishes New Facility
Pingtung Agricultural to Set Up an Exclusive Veterinary Park
Ouro Fino To Expand Veterinary Product Suite
Alpharma Acquires Yantai Jinhai
Pfizer Animal Health Acquires Embrex
Schering-Plough Acquires Intervet
Schering-Plough Acquires Organon BioSciences
Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer
Crucell Licenses PER.C6® Technology to Pfizer Animal Health
Central Veterinary Research Laboratory to Synthesize New Animal Vaccines
Pfizer to Shut Down Omaha Animal Vaccine Center
IGI Licenses Novasomes to Novavax
Bogor Agricultural Institute Collaborates with Shigeta Animal Pharmaceuticals
Suguna Poultry Steps into Livestock Vaccine Production Business
European Medicines Agency Grants Community Authorization for Nobilis Influenza H7N1
AVANT Immunotherapeutics & Pfizer Collaborate to Develop Animal Vaccines
Intervet International Acquires FMD Vaccine Production Facility from Bayer Healthcare
Canadian Food Inspection Agency Authorizes Bioniche E. Coli O157:H7 Cattle Vaccine for Field Use
Hemispherx Biopharma Acquires DOGS Molecule Patent
Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala
Cryosite and Animal Health Australia Form Partnership
Hester Pharmaceuticals Plans Capacity Expansion
Biovet to Set up Animal Vaccine Plant in Karnataka
Bogor Institute of Agricultureand Shigeta Establish JV for Production of CLOSE 5.1 Vaccine
IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune
Bioject Medical Technologies Signs Three Agreements WithMerial
PetCARE Television Network signs Distribution Agreement with Butler Animal Health Supply
Poultry Vaccine to be produced in Vladimir
9.FOCUS ON SELECT GLOBAL PLAYERS
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Heska Corporation (US)
Imugene Limited (Australia)
Indian Immunologicals Ltd (India)
Lohmann Animal Health (US)
Merck & Co., Inc. (US)
Merck Animal Health
Merial Ltd. (US)
Pfizer, Inc. (US)
Pfizer Animal Health Global Poultry
Fort Dodge Animal Health (US)
Protein Sciences Corporation (US)
Virbac Corporation (US)
10.GLOBAL MARKET PERSPECTIVE
III. MARKET1.THE UNITED STATES
A. Market Analysis
H5N1 Virus: A Conundrum for the US Industry
Rabies Cases in the US
B. Market Analytics
2.EUROPE
Market Analysis
2A.FRANCE
Market Analytics
2B.GERMANY
Market Analytics
2C.ITALY
Market Analytics
2D.THE UNITED KINGDOM
Market Analytics
2E.REST OF EUROPE
A. Market Analysis
A Note on Danish Veterinary Services
The 2002 Standards of Danish Medicines recommends test for antibody inducing fragments in veterinary vaccines
Hungary Vaccinates Birds Across Zoos
Russia Mass-Produces Vaccines Against Avian Flu
B. Market Analytics
3.REST OF WORLD
A. Market Analysis
Focus on Select Regions
Canada
Overview of Canadian Animal Health Industry
Import and Manufacture of Veterinary Biologics
First to Access E. coli 0157:H7 Vaccine
China
A Glance at the Animal Vaccine Market in China
China Initiates Mass Vaccination Campaign Against Bird Flu Virus
Australia
A Note on Australian Veterinary Therapeutics Market
India
ICAR Develops Indigenous Bird Flu Vaccine
Thailand
Japan & Thailand to Cooperate for Developing Bird Flu Vaccine
Taiwan
Taiwan’s Animal Healthcare Industry Under Scan
Malaysia
Malaysia Initiates Measures to Deal with Potential Flu Pandemic
Kazakhstan
Kazakhstan Takes Proactive Measures Against Bird Flu
North Korea
North Korea Develops Bird Flu Vaccine
Vietnam
Vietnam Imports Bird Flu Vaccines
Egypt
Egypt Reports H5N1 Infection in Vaccinated Flocks
Kenya
Kenya Mass-Manufactures Vaccines Against Rift Valley Fever
B. Market Analytics
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 69 (including Divisions/Subsidiaries - 97)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Italy
Rest of Europe
Asia-Pacific (Excluding Japan)
Latin America
Africa
Middle-East3
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. Companion Animal Vaccines
B. Livestock Vaccines
Porcine Vaccines
Bovine Vaccines
Poultry Vaccines
Ovine Vaccines
Equine Vaccines
Other Animal Vaccines
II. EXECUTIVE SUMMARY1.INDUSTRY OVERVIEW & OUTLOOK
Global Animal Health Care Industry - A Brief Review
Table 1. Global Animal Health Products Market by Region (2011): Percentage Share Breakdown by Value Sales for North America, Europe, Latin America and Rest of World (includes corresponding Graph/Chart)
Table 2. Global Animal Health Products Market by Product Group (2011): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medical Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart)
Animal Healthcare Market Grows Amidst Recession
Veterinary Vaccines Industry Posts Moderate Growth
Poultry Vaccines Industry: A Global Scenario
Improved Manufacturing Techniques
Improved Analysis
Scope of the Report
2.MARKET TRENDS & ISSUES
Companion Animal Vaccines: Trailing on a High Growth Track
OTC Market: A Potential Threat for Veterinarians
Small Animal Practitioners Feel the Pinch of Recession
Parasiticides, Systemic Agents To Drive The Market
Taxonomy of Vaccines
Bird Flu – The Aftermath
Vaccination – Critical for Controlling Avian Influenza Virus
3.PRODUCT OVERVIEW
Vaccines - An Evolutionary Scan
Contribution of Animal Research to Vaccine Production
Veterinary Medicines- A Brief Review
Preventive Medicines
Therapeutic Medicines
Others
Development of Vaccines
Production of Vaccines
Veterinary Vaccines – An Essential Component of Animal Health Care
What Does A Veterinary Vaccine Do?
Classification of Veterinary Vaccines
Companion Animals Vaccines
Canine Vaccines
Feline Vaccines
Livestock Vaccines
Bovine Vaccines
Poultry Vaccines
Ovine Vaccines
Porcine Vaccines
Equine Vaccines
Aquaculture Vaccines
A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
Vaccination and Its Reactions
Veterinary Vaccines- Latest Breakthroughs
Marker vaccines
DNA vaccines
Gene-deleted vaccines
Viral-vectored vaccines
4.NOTES ON SELECT ANIMAL DISEASES
Brucellosis
Tuberculosis
Johne’s disease
Spirochete Associated Diseases
Respiratory Disease in Goats, Sheep, and Cattle
Porcine Respiratory Diseases
Mastitis
African Swine Fever
Avian Influenza
East Coast Fever
Hemorrhagic Septicemia
Foot-And-Mouth Disease
Japanese Encephalitis
Rift Valley Fever
Equine Virus
5.PRODUCT INNOVATIONS/INTRODUCTIONS
Intervet/Schering-Plough Animal Health Introduces a New Web Site for Innovax recombinant Vaccines Product Line
Pfizer Animal Health Introduces the First E. Coli Bacterial Extract Vaccine
Intervet Schering-Plough Animal Health Re-Launches EQUILIS® StrepE for Horses
Boehringer Ingelheim Vetmedica Launches Single Shot 3FLEX combination package PL
Pfizer Animal Health Launches INFORCE™ 3
Boehringer Ingelheim Introduces Ingelvac CircoFLEX® in Russia
Pfizer Animal Health Introduces Bopriva® for Bull and Beef Market in NZ
GALVmed, Inter-African Bureau for Animal Resources Launch ECF Vaccine
BIVI launches Five New Variants of Vetera® Vaccines
Hipra Announces Launch of Suiseng®
Aceto Corporation Receives Approval to Sell Suppliera[euro]™ in the US
Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs
Intervet Schering-Plough Animal Health Introduces PORCILIS PCV Vaccine
Lohmann Launches AviPro® MEGAN®VAC Vaccination for Salmonella Disease
Intervet Schering Plough Animal Health Introduces Circovirosis Vaccine
Pfizer Animal Health Develops Inovocox® Vaccine
Intervet/Schering-Plough Animal Health Launches Bravoxin 10
Bioject and Merial Rolls Out Derma-Vac NF
Defra to Launch Bovine Tuberculosis Vaccine
6.PRODUCT INTRODUCTIONS/INNOVATIONS – A HISTORIC PERSPECTIVE BUILDER
Intervet International Develops Bluetongue Vaccine
Hester Biosciences Unveils Anti-Coryza Vaccine
Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8 Vaccine
Tecnovax Develops Vaccine for Salmon Virus
Tamil Nadu Veterinary and Animal Science University and The Indian Veterinary Research Institute Develop Vaccine
Lohmann Animal Health Develops AviPro IBD Xtreme
Intervet/Schering-Plough Animal Health Launches EquiRab™
Lohmann Animal Health Introduces Larger Doses of AviPro® ViBursa CE
Lohmann Animal Health International Rolls Out AviBlue
Fort Dodge Animal Health Unveils West Nile-Innovator DNA
Univet Agricultural Products Introduces Coglapest
Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C
Pfizer Animal Health Unveils FluSure® XP Defense System
Pfizer Animal Health Launches Improvac®
Intervet/Schering-Plough Animal Health Develops Onset™ 5 Intranasal (IN) Vaccine
Merial Rolls Out BTVPUR AlSap 8
Pfizer Animal Health Introduces FarrowSure® GOLD and FarrowSure® GOLD B
Schering-Plough Animal Health Unveils CAVALRY 9
Lohmann Animal Health Develops BTO2 REO Vaccine
Agroinsuvet Introduces New Vaccines
Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for Poultry Industry
Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine Prototype for Birds
Schering-Plough Receives USDA License for its Rhusigen™ Erysipelas Vaccine
USDA Approves Use of PreveNile™ Vaccine for Horses
Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine
Boehringer Ingelheim’s Swine Vaccine Gains Approval in Australia
Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs
Embrex’s Poultry Vaccine Inovocox Gets USDA Approval
Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine
United States Department of Agriculture Grants Conditional License for Necrotic Enteritis Vaccine
Fort Dodge Receives USDA License for Pyramid®10
USDA Licenses Use of Fort Dodge’s Suvaxyn® PCV2 Vaccine in Pigs
USDA Grants Conditional License to Pfizer’s New Canine Vaccine
7.RECENT INDUSTRY ACTIVITY
Pfizer to Restructure Indian Animal Health Unit
Pfizer Poultry Health Acquires Alpharma
Intervet/Schering-Plough Animal Health Becomes Merck Animal Health
Centegen Enters into Licensing Partnership with Merial
The Ugandan Government Enters into Partnership with Brentec Vaccines International
Pfizer Animal Health Kicks Off Equine Business Unit
Pfizer Animal Health Acquires Microtek
GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine
Pfizer Animal Health Inks Global Licensing Deal with Epitopix
Indian Immunologicals Intends to Establish a New Facility in Hyderabad
Pfizer Phases out Animal Vaccine Manufacturing Unit of Wyeth in the Netherlands
Vivalis Signs Commercial License for EB66® Cell Line Platform
Ibio Grants Rights of iBioLaunch platform to Government Funded Project
Intervet/Schering-Plough Animal Health Unveils Production Center at Boxmeer
Globion India Announced Plans to Develop Eight New Vaccines
Veterinary Services Department Intends to Upgrade VRI
VIVALIS Grants Rights of EB66® Cell Line To KYOTO BIKEN
Vical Enters Into Agreement with GenomIdea for Development of DNA Vaccine
Intervet/Schering-Plough Animal Health Unveils the New Freeze-drying and Specialized Central Filling Unit
Him Electronics Enters into Partnership with Hester Bioscience to Produce Animal Vaccines
Intervet/Schering-Plough Animal Health Receives Approval for Nobivac Lepto4
Biolex Enters into Collaboration With Merial for Research and Development
Intervet/Schering-Plough Animal Health Receives Full License from USDA for Nobivac® Vaccine
Intercell Inks License Agreement with Boehringer
Intervet/Schering-Plough Recalls PreveNile West Nile Virus Vaccine in the US
Merial Gains Full License of ONCEPT™ from USDA
Virbac Acquires Veterinary Assets from Pfizer
Harbin Pharmaceutical Group Holding Acquires Animal Vaccine Business From Pfizer
Boehringer Ingelheim Acquires Certain Cattle Vaccines from Fort Dodge
Virbac Acquires 30% Share in Santa Elena
Merck and Sanofi-Aventis to Merge their Animal Health Business
Elanco to Take Over Pfizer’s Animal Health Products Portfolio
Boehringer Ingelhei to Acquire Pfizer’s Fort Dodge Animal Health Unit
ImmunoVaccine Inks Deal with Pfizer
Merck Merges with Schering-Plough
Pfizer Acquires Wyeth
Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine
Epitopix Obtains Approval to Sell Siderophore Receptor and Porin Vaccine
Phibro Animal Health Acquires Animal Health Division of Abic
Fort Dodge Animal Health and Vivalis Sign Commercial License Deal
Hester Biosciences Expands Gujarat Based Facility
Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR Vaccine with Bovilis® IBR Marker Live
Tangshan Yian Biological Engineering Wins Approval from Ministry of Agriculture of China
Lohmann Animal Health International Signs an Agreement with Celldex Therapeutics
Intervet/Schering-Plough Animal Health Starts New Manufacturing Facility
Laprovet Commences New Facility
ImmunoVaccine Technologies and La Jolla Institute for Allergy & Immunology Enter into an Agreement
Merial Signs a Toll Distribution and Manufacturing Agreement with Newport Laboratories
BOEHRINGER INGELHEIM Animal Health Signs Research License Deal with Vivalis
AviTech Selects Merial as a Distributor and Service Provider
8.STRATEGIC CORPORATE DEVELOPMENTS – A HISTORIC PERSPECTIVE BUILDER
Bayer Inks Agreement with Juvaris
Pfizer Inks Agreement with ImmunoVaccine Technologies
BioVet Inaugurates BSL-4 Production Unit in India
Vaxine to Take over Protein Sciences
Pfizer Inaugurates a New Development Facility for Veterinary Vaccines
Merial to Establish Animal Vaccine Manufacturing Plant
BNC Bioniche Life Sciences Bags Approval to Sell Econiche Vaccines
Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division
Pfizer's Animal Health Unit Acquires Schering-Plough's Product License in Europe
Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario
Harbin Veterinary Research Institute Opens Animal Vaccine Manufacturing Base
Bioject Medical Technologies Enters into a Long-Term Supply, Development and License Contract with Merial
Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough
Biochemiq Enters into Partnership with Labovet
Microbix Biosystems Purchases Production Plant
Beijing Veterinary Biological Product Factory Starts Operation in New Plant
Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine Facility
Schering-Plough to Sell Health Products of Animals to Pfizer and Virbac
Pfizer Group Establishes a Veterinary Vaccines Development Center
Phylaxia to Acquire Gazdasagi Radio and Kozep-europai Gazterminal Zrt
Bayer HealthCare AG's Animal Health Unit Enters into Licensing Agreement with Juvaris BioTherapeutics
Vivalis Enters into a Commercial License Contract with Virbac
ImmunoVaccine Technologies Signs Licensing Agreement with Pfizer Animal Health
Kaketsuken and Vivalis Extends Research Collaboration
Heska Amends Distribution Contract with Agri Laboratories
Prevtec Microbia and Saskatchewan Research Council Receives Approval to Market and Manufacture Coliprotec
Imugene and Merial Enter into an Agreement
Celldex Therapeutics Merges with AVANT Immunotherapeutics’ Subsidiary
Ceva Sante Animale Acquires Delvet
Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals
Environmental Risk Management Authority Approves equine Influenza Vaccine
Functional Technologies Commences Operations of Phyterra Bio
Summit VetPharm Enters into Distribution Partnership with Webster Veterinary Unit
PerOs Receives Establishment and Bacterin License from USDA
Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines
Boehringer Ingelheim Vetmedica Receives Approval for Express® FP and Express® Vaccines from the USDA
Merial Bags Major Australian Contract
United States Department of Agriculture Approves Intervet Vaccine
Merial Pockets Ancare
Heska Revises Distribution Agreement with AgriLabs
Animal Health International Acquires Kane Veterinary Supplies
Industrial Equity Investments Pockets Arysta LifeScience
Henry Schein Acquires W&J Dunlop
Tecnovax Establishes New Facility
Pingtung Agricultural to Set Up an Exclusive Veterinary Park
Ouro Fino To Expand Veterinary Product Suite
Alpharma Acquires Yantai Jinhai
Pfizer Animal Health Acquires Embrex
Schering-Plough Acquires Intervet
Schering-Plough Acquires Organon BioSciences
Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer
Crucell Licenses PER.C6® Technology to Pfizer Animal Health
Central Veterinary Research Laboratory to Synthesize New Animal Vaccines
Pfizer to Shut Down Omaha Animal Vaccine Center
IGI Licenses Novasomes to Novavax
Bogor Agricultural Institute Collaborates with Shigeta Animal Pharmaceuticals
Suguna Poultry Steps into Livestock Vaccine Production Business
European Medicines Agency Grants Community Authorization for Nobilis Influenza H7N1
AVANT Immunotherapeutics & Pfizer Collaborate to Develop Animal Vaccines
Intervet International Acquires FMD Vaccine Production Facility from Bayer Healthcare
Canadian Food Inspection Agency Authorizes Bioniche E. Coli O157:H7 Cattle Vaccine for Field Use
Hemispherx Biopharma Acquires DOGS Molecule Patent
Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala
Cryosite and Animal Health Australia Form Partnership
Hester Pharmaceuticals Plans Capacity Expansion
Biovet to Set up Animal Vaccine Plant in Karnataka
Bogor Institute of Agricultureand Shigeta Establish JV for Production of CLOSE 5.1 Vaccine
IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune
Bioject Medical Technologies Signs Three Agreements WithMerial
PetCARE Television Network signs Distribution Agreement with Butler Animal Health Supply
Poultry Vaccine to be produced in Vladimir
9.FOCUS ON SELECT GLOBAL PLAYERS
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Heska Corporation (US)
Imugene Limited (Australia)
Indian Immunologicals Ltd (India)
Lohmann Animal Health (US)
Merck & Co., Inc. (US)
Merck Animal Health
Merial Ltd. (US)
Pfizer, Inc. (US)
Pfizer Animal Health Global Poultry
Fort Dodge Animal Health (US)
Protein Sciences Corporation (US)
Virbac Corporation (US)
10.GLOBAL MARKET PERSPECTIVE
Table 3. World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 4. World Historic Review Veterinary Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 5. World 15-Year Perspective for Veterinary Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart)
Table 6. World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 7. World Historic Review for Companion Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 8. World 15-Year Perspective for Companion Animal Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 9. World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 10. World Historic Review for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 11. World 15-Year Perspective for Companion Animal Vaccines by Product Segment – Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 12. World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 13. World Historic Review for Canine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 14. World 15-Year Perspective for Canine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 15. World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 16. World Historic Review for Feline Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 17. World 15-Year Perspective for Feline Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart)
Table 18. World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 19. World Historic Review for Livestock Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 20. World 15-Year Perspective for Livestock Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 21. World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment – Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 22. World Historic Review for Livestock Vaccines by Product Segment – Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 23. World 15-Year Perspective for Livestock Vaccines by Product Segment – Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 24. World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 25. World Historic Review for Porcine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 26. World 15-Year Perspective for Porcine Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 27. World Recent Past, Current and Future Analysis for Bovine Vaccines by Geographic Region – US, Europe & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 28. World Historic Review for Bovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 29. World 15-Year Perspective for Bovine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart)
Table 30. World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 31. World Historic Review for Poultry Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 32. World 15-Year Perspective for Poultry Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 33. World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 34. World Historic Review for Ovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 35. World 15-Year Perspective for Ovine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart)
Table 36. World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 37. World Historic Review for Equine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 38. World 15-Year Perspective for Equine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 39. World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 40. World Historic Review for Other Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 41. World 15-Year Perspective for Other Animal Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
III. MARKET1.THE UNITED STATES
A. Market Analysis
H5N1 Virus: A Conundrum for the US Industry
Rabies Cases in the US
B. Market Analytics
Table 42. US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 43. US Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 44. US 15-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2.EUROPE
Market Analysis
Table 45. European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 46. European Historic Review for Veterinary Vaccines by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 47. European 15-Year Perspective for Veterinary Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 48. European Recent Past, Current & Future for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 49. European Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 50. European 15-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2011 & 2017(includes corresponding Graph/Chart)
2A.FRANCE
Market Analytics
Table 51. French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 52. French Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 53. French 15-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2B.GERMANY
Market Analytics
Table 54. German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 55. German Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 56. German 15-Year Perspective for Veterinary Vaccines by Product Group/ Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2C.ITALY
Market Analytics
Table 57. Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 58. Italian Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 59. Italian 15-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2D.THE UNITED KINGDOM
Market Analytics
Table 60. UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 61. UK Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 62. UK 15-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2E.REST OF EUROPE
A. Market Analysis
A Note on Danish Veterinary Services
The 2002 Standards of Danish Medicines recommends test for antibody inducing fragments in veterinary vaccines
Hungary Vaccinates Birds Across Zoos
Russia Mass-Produces Vaccines Against Avian Flu
B. Market Analytics
Table 63. Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines – by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 64. Rest of Europe Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 65. Rest of Europe 15-Year Perspective for Veterinary Vaccines by Product/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
3.REST OF WORLD
A. Market Analysis
Focus on Select Regions
Canada
Overview of Canadian Animal Health Industry
Import and Manufacture of Veterinary Biologics
First to Access E. coli 0157:H7 Vaccine
China
A Glance at the Animal Vaccine Market in China
China Initiates Mass Vaccination Campaign Against Bird Flu Virus
Australia
A Note on Australian Veterinary Therapeutics Market
India
ICAR Develops Indigenous Bird Flu Vaccine
Thailand
Japan & Thailand to Cooperate for Developing Bird Flu Vaccine
Taiwan
Taiwan’s Animal Healthcare Industry Under Scan
Malaysia
Malaysia Initiates Measures to Deal with Potential Flu Pandemic
Kazakhstan
Kazakhstan Takes Proactive Measures Against Bird Flu
North Korea
North Korea Develops Bird Flu Vaccine
Vietnam
Vietnam Imports Bird Flu Vaccines
Egypt
Egypt Reports H5N1 Infection in Vaccinated Flocks
Kenya
Kenya Mass-Manufactures Vaccines Against Rift Valley Fever
B. Market Analytics
Table 66. Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 67. Rest of World Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 68. Rest of World 15-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 69 (including Divisions/Subsidiaries - 97)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Italy
Rest of Europe
Asia-Pacific (Excluding Japan)
Latin America
Africa
Middle-East3
